Dapiglutide

MCE 国际站：Dapiglutide

CAS：2296814-85-0

品牌：MedChemExpress (MCE)

存储条件：Please store the product under the recommended conditions in the Certificate of Analysis.

生物活性：Dapiglutide (ZP7570) 是一种长效胰高血糖素样肽-1 受体 1R (GLP-1R)/胰高血糖素样肽-2 受体 (GLP-2R) 双重激动剂。达匹鲁肽可用于短肠综合征（SBS）的研究
^[1]。

热销产品：Ravuconazole | Roxithromycin | PS48 | Tilmicosin | DEL-22379 | (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(tert-butoxy)-5-oxopentanoic acid | Tebuconazole | Pelcitoclax | SWE101 | KRAS G12D inhibitor 14

研究领域：GPCR/G Protein

作用靶点：GCGR

热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸

Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides

参考文献：
[1]. Zealand Pharma doses first subject in Phase 1 clinical trial with potential next generation dual-acting peptide therapeutic for short bowel syndrome. 26 June 2019.

原创作者：MedChemExpress